Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Ragosa Mark, Chief Financial Officer. Insider active across 2 companies, notably Kiniksa Pharmaceuticals, Ltd.. Aggregated, 36 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €430k. Activity tracked since 3 January 2024. The latest transaction was filed on 7 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Ragosa Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
991 sharesClass A Common ShareSEC:0001415889-24-011764:0
25 of 36 declarations
About Ragosa Mark
Mark Ragosa is the Chief Financial Officer of Kiniksa Pharmaceuticals, Ltd. In this role, he oversees the company's financial management, including financial planning and investment strategy. His expertise is crucial for Kiniksa's growth and financial viability.